Equities
Health CareMedical Equipment and Services
  • Price (AUD)24.50
  • Today's Change-0.50 / -2.00%
  • Shares traded488.44k
  • 1 Year change-9.02%
  • Beta0.7832
Data delayed at least 20 minutes, as of May 29 2024 07:10 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 15-Jun-23
  • 14-Mar-24
  • 18-Apr-24
  • 16-May-24
  • 23-May-24
Select bar for recommendation details.
Recommendations23-May-24
Buy1
Outperform4
Hold6
Underperform1
Sell0

Share price forecast in USD

The 11 analysts offering 12 month price targets for Ansell Ltd have a median target of 26.57, with a high estimate of 30.71 and a low estimate of 22.69. The median estimate represents a 8.46% increase from the last price of 24.50.
High25.3%30.71
Med8.5%26.57
Low-7.4%22.69

Dividends in USD

In 2023, Ansell Ltd reported a dividend of 0.46 USD, which represents a 16.50% decrease from last year. The 13 analysts covering the company expect dividends of 0.40 USD for the upcoming fiscal year, a decrease of 14.26%.
Div growth (TTM)-16.50%
More ▼

Earnings history & estimates in USD

Ansell Ltd reported annual 2023 earnings of 1.17 per share on Aug 13, 2023.
Average growth rate+6.74%
More ▼

Revenue history & estimates in USD

Ansell Limited had revenues for the full year 2023 of 1.66bn. This was 15.21% below the prior year's results.
Average growth rate+3.59%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.